Member-only story

Oxidative Stress and Redox Signaling in Parkinson's Disease: Unraveling the Molecular Mechanisms for Therapeutic Advancements

Kirk Hayes

·8.2k Followers· Follow

Published in Oxidative Stress And Redox Signalling In Parkinsons Disease (ISSN 34)

6 min read · 1 month before

836 View Claps

83 Respond

Save

Listen

Parkinson's disease, a debilitating neurodegenerative disFree Download, is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. This neuronal loss is accompanied by a complex interplay of cellular and molecular mechanisms, with oxidative stress and redox signaling emerging as key players in the disease pathogenesis.

Oxidative Stress and Redox Signalling in Parkinsons Disease (ISSN 34)

Oxidative Stress and Redox Signalling in Parkinsons Disease (ISSN Book 34)

by Leland Olson

4.6 out of 5

Language	:	English
File size	:	2679 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	537 pages

In this article, we delve into the intricate relationship between oxidative stress, redox signaling, and Parkinson's disease. We explore the molecular mechanisms underlying their involvement and discuss the potential therapeutic strategies aimed at modulating these processes for disease management.

Oxidative Stress in Parkinson's Disease

Oxidative stress, an imbalance between the production of reactive oxygen species (ROS) and the body's antioxidant defense systems, is a hallmark of Parkinson's disease. Excessive ROS levels can lead to oxidative damage of cellular components, including proteins, lipids, and DNA.

In the context of Parkinson's disease, mitochondrial dysfunction is a major contributor to oxidative stress. Impaired mitochondrial function results in increased ROS production, which can damage mitochondrial proteins and DNA, leading to a vicious cycle of oxidative damage.

Diagram Illustrating The Role Of Oxidative Stress In Parkinson's Disease Oxidative Stress And Redox Signalling In Parkinsons Disease (ISSN 34)

Redox Signaling in Parkinson's Disease

Redox signaling, the interplay between oxidation and reduction reactions, is essential for cellular function. In Parkinson's disease, redox signaling is dysregulated, leading to both beneficial and detrimental effects.

On the one hand, redox signaling can activate protective pathways that promote cell survival and neuroprotection. For instance, the transcription factor Nrf2, activated by redox signaling, induces the expression of antioxidant and detoxifying enzymes that counteract oxidative stress.

On the other hand, excessive or sustained redox signaling can promote neuroinflammation and neuronal death. Oxidized proteins and lipids can activate pro-inflammatory signaling cascades, leading to the release of inflammatory mediators that exacerbate neuronal damage.

Diagram Illustrating The Role Of Redox Signaling In Parkinson's Disease Oxidative Stress And Redox Signalling In Parkinsons Disease (ISSN 34)

Therapeutic Implications

Understanding the role of oxidative stress and redox signaling in Parkinson's disease has significant implications for therapeutic strategies. Modulating these processes could provide novel avenues for neuroprotection and disease modification.

Antioxidant therapies, aimed at reducing oxidative stress, have shown promise in preclinical studies. However, clinical trials have yielded mixed results, highlighting the complexity of targeting oxidative stress in a neurodegenerative setting.

Another therapeutic approach focuses on modulating redox signaling pathways. Upregulating Nrf2 signaling, for example, has shown neuroprotective effects in animal models of Parkinson's disease. Additionally, targeting inflammatory signaling cascades activated by redox dysregulation could provide therapeutic benefits.

Oxidative stress and redox signaling play a crucial role in the development and progression of Parkinson's disease. Understanding the molecular mechanisms underlying their involvement is essential for developing effective therapeutic strategies.

Ongoing research continues to unravel the complexities of oxidative stress and redox signaling in Parkinson's disease. With advancements in our knowledge, we can anticipate the development of novel and targeted therapies to halt or slow the progression of this debilitating neurodegenerative disFree Download.

References

Dauer, W., & Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron, 39(6),889-909.
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004). Neurodegenerative diseases and oxidative stress. Nature Reviews Drug Discovery, 3(3),205-214.
Dias, V., Junn, E., & Mouradian, M. M. (2013). The role of oxidative stress in Parkinson's disease. Journal of Parkinsons Disease, 3(4),461-491.
Reddy, P. H. (2013). Mitochondrial dysfunction in Parkinson's disease: mitochondrial complex I deficiency, oxidative stress, and apoptosis. Neurochemical Research, 38(1),301-310.
Schapira, A. H. (2009). Mitochondrial dysfunction in Parkinson's disease. Annals of Neurology, 66(5),584-591.
Mazzio, E., & Solimena, M. (2011). Redox control of transcription: molecular mechanisms and physiological implications. Antioxidants & Redox Signaling, 14(1),1-18.
Wang, X., & Michaelis, E. K. (2010). Selective neuronal vulnerability to oxidative stress in the brain: Involvement of Nrf2 and GSH systems. Free Radical Biology and Medicine, 49(4),1529-1541.
Hirsch, E. C., Hunot, S., & Hartmann, A. (2006). Neuroinflammatory processes in Parkinson's disease. Parkinsonism & Related DisFree Downloads, 12(Suppl 1),S3-S10.
Przedborski, S., & Ischiropoulos, H. (2005). Reactive oxygen species as mediators of neurotoxicity. Annals of the New York Academy of Sciences, 1042, 1-11.
Gandhi, S., Abramov, A. Y., & Qi, X. (2015). Nrf2-mediated redox signaling in Parkinson's disease. Antioxidants & Redox Signaling, 22(3),257-271.
Di Monte, D. A., & Sandy, M. S. (2007). Therapeutic potential of antioxidants in neurodegenerative disFree Downloads. Expert Opinion on Investigational Drugs, 16(12),1887-1897.
Dexter, D. T., & Jenner, P. (2010). Oxidative stress as a cause of Parkinson's disease. Current Opinion in Neurobiology, 20(1),70-76.
Koutalas, P., Stamoulakatou, A., Nikolaou, C., & Vassilopoulos, D. (2015). The role of oxidative stress and inflammation in Parkinson's disease. Current Neuropharmacology, 13(1),148-160.
Lingor, P., & Koch, J. C. (2013). Targeting mitochondrial dysfunction in Parkinson's disease: a complex issue. Current Opinion in Neurology, 26(4),443-450.